Table 3 Associations with mortality and lost to Follow-up in AIDS-KS patients
Unadjusted | Adjusted | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Gender | ||||||
Male | 1.0 | |||||
Female | 1.1 | (0.7-1.6) | 0.745 | 1.0 | (0.6-1.6) | 0.985 |
Age | ||||||
≤35 years | 1.0 | |||||
>35 years | 1.2 | (0.8-1.7) | 0.435 | 1.1 | (0.7-1.8) | 0.614 |
Baseline CD4 count | ||||||
≤100 cells/μl | 1.0 | |||||
>100 cells/μl | 0.6 | (0.4-0.9) | 0.012 | 0.7 | (0.4-1.2) | 0.194 |
KS Stage | ||||||
T0 | 1.0 | |||||
T1 | 2.4 | (1.6-3.8) | <0.001 | 3.3 | (2.0-5.5) | <0.001 |
S0 | 1.0 | |||||
S1 | 3.2 | (1.5-6.6) | 0.002 | 2.4 | (1.1-5.2) | 0.021 |
cART | ||||||
Yes | 1.0 | |||||
No | 3.4 | (2.2-5.3) | <0.001 | 4 | (2.4-6.6) | <0.001 |
Chemotherapy | ||||||
Yes | 1.0 | |||||
No | 1.3 | (0.8-2.1) | 0.333 | 1.9 | (1.1-3.5) | 0.025 |
Radiation Therapy | ||||||
Yes | 1.0 | |||||
No | 1.4 | (0.9-2.3) | 0.168 | 1.3 | (0.8-2.2) | 0.356 |